GLU-微管蛋白作為對呋咱並苯並咪唑類的藥物反應的生物標誌物的用途
- 专利权人:
- BASILEA PHARMACEUTICA AG
- 发明人:
- LANE, Heidi Alexandra,BACHMANN, Felix
- 申请号:
- HK14105637.2
- 公开号:
- HK1192323B
- 申请日:
- 2014.06.13
- 申请国别(地区):
- HK
- 年份:
- 2016
- 代理人:
- 摘要:
- Use of glu-tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazole compound of general formula (I).
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Use of glu tubulin as a biomarker of drug response to furazanobenzimidazoles
- USE OF GLU-TUBULIN AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES
- Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
- Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
- USE OF GLU-tubulin as a biomarker of PHARMACEUTICAL RESPONSE TO FURAZANOBENZIMIDAZOLER